久久久精品欧美一区二区三区,国产欧美久久久精品影院,亚洲AV福利天堂一区二区三亚洲欧洲日韩国产AⅤ在线,亚洲成av人在线视,四虎国产精品永久地址99自拍三区一级国产片,亚洲男人的天堂久久无在线观看免费黄视频,亚洲一级特黄大片在线播放,国产成人精品区在线观看

Vaccine
Home > Application > Vaccine > Virus-like particle (VLP) vaccine

Virus-like particle (VLP) vaccine

Most currently available vaccines are mainly based on inactivated or attenuated live vaccines. Although these traditional vaccines have been used effectively against various infectious diseases, some of them have several limitations, including low likelihood of inducing a stronger immune response and their poor efficacy. Recent outbreaks of infectious diseases demonstrate the need to develop robust vaccines to overcome these limitations. The main challenge is to develop new technical approaches and boost immunity without compromising safety, efficacy and tolerability. Recent advances in vaccines based on DNA, mRNA, and recombinant viral vectors provide effective vaccine development methods for difficult-to-target pathogens and control infectious disease outbreaks.


Virus-like particle (VLP) technology provides an alternative platform for the development of effective vaccines against serious infectious diseases, and it is being developed in parallel with vaccines based on mRNA and viral vectors. VLPs are also much more immunogenic than other subunit vaccines because they present repetitive epitopes on their surface, making them more reliably detectable by the immune system. On the other hand, subunit vaccines may be less immunogenic due to misfolding of the target antigen or insufficient presentation to the immune system, and moreover, they require adjuvants and repeated vaccinations to elicit an adequate immune response. The term virus-like particle was first described by Fraenkel-Conrat and Williams (1955) by recombining tobacco mosaic virus (TMV) particles from purified RNA and protein components. The potential of these nanostructures to induce potent immune responses was then further investigated. The VLP platform can overcome various problems typically associated with traditional vaccines; specifically, infectivity, reversion to virulent forms, mutation risk associated with live attenuated vaccines, and reduced immunogenicity, toxicity instability, low yield and long formulation time associated with inactivated vaccines.


These bio-inspired nanostructures feature repetitive and high-density antigens from different viruses, helping to trigger a strong immune response. Furthermore, these highly immunogenic molecules possess the self-assembling properties of viral proteins. They are biocompatible and have the potential for structural flexibility during synthesis. They can be chemically or genetically modified and exhibit increased stability, uniformity, and functionality, and are considered effective tools in various biomedical applications. Depending on the presence or absence of a lipid membrane, VLPs can be classified as either enveloped or nonenveloped.


However, some of the key challenges associated with VLPs are low stability, difficult downstream processes, high production costs, and sensitivity to environmental conditions. Many different VLPs have been synthesized in various expression systems, such as bacteria, yeast, mammalian cells, insect cells, and plants. VLP-based vaccines have the potential to be used to treat various infectious diseases, including HIV, influenza, hepatitis B, hepatitis E, malaria, Ebola virus, SARS-CoV-2, Zika virus, dengue fever, and foot-and-mouth disease, among others. Several VLP-based vaccines have been licensed and marketed, including Engerix-B? and Recombivax HB? for HBV, Gardasil? and Cervarix? for HPV, Hecolin? for HEV, and Mosquirix? for malaria.

Related Products
Contact Us
  • Tel.: +86 021 6434 0155
  • E-Mail: marketing@duoningbio.com
  • Address: Building 30, No. 1525 Minqiang Road, Songjiang District, Shanghai
Message

Copyright ? Shanghai Duoning Biotechnology Co., Ltd. All Rights Reserved Sitemap | Technical Support: Reanod

WeChat
WeChat

Message-

Duoning Biotechnology

+86 021 6434 0155

白丝美女被操黄色视频国产免费| 亚洲欧美日本韩国| 少妇无码太爽了不卡在线观看| 77777亚洲午夜久久多喷 | 国产无码免费视频在线| 欧美一区日韩二区亚洲三区在线观看| 国产专区国产av一区2020| 精品视频在线观看一区二区| 大肉大捧一进一出好爽视频MBA| 中文字幕一区在线观看视频| x8x8拨牐拨牐x8免费视频8午夜| 欧美成人精品一区二区久久久| 久久福利无码一区二区三区| 亚洲人成无码网站久久99热国产| 亚洲AV中文无码乱人伦在线咪咕| 午夜精品久久久久久久无码| 国产色诱视频在线播放丝袜| 免费看女人下部被啪流水视频| 国产超爽人人爽人人做| 少妇人妻偷人精品视频| 极品白嫩美女白浆成人福利在线看| 欧美精品在线一区二区三区在线a | 无码4800YY私人影院在线看| 精品丰满人妻无套内射| 中文字幕无码视频专区在线播放| 成人a级视频在线观看| 久久99精品久久久久子伦| 成人h视频在线观看| 国产午夜精品一区二区三区| 欧洲美熟女乱又伦| 无码久久综合久中文字幕| Aa无码人妻一区二区三区 | 免费无码又爽又刺激高潮虎虎视频| 性一交一乱一乱一视频| 91久久青青青国产免费| 久久久久无码精品国产不卡| 精品无码中出一区二区| 亚洲AV成人无码国产一区二区| 久久久亚洲精品无码| 天天影视综合网网综合久久0| 国产一区二区三区怡红院|